To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS
Status:
Withdrawn
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the effects of a therapeutic dose of arbaclofen extended
release (ER) tablets compared with placebo on human sperm concentration, motility, and
morphology in male subjects with multiple sclerosis (MS).